PRE (prenetics.com) שווי פירמה כולל

Prenetics Global (PRE) leads the DNA diagnostics sector, serving private and corporate clients worldwide. However, political fragmentation hinders reagent supplies and limits the expansion of its laboratory network. Market share price fluctuations demonstrate that the enterprise value is 202.35. An influx of health-conscious consumers is driving demand, while strict government accuracy standards create a robust defensive barrier for the business.

The stability of Prenetics Global (PRE) is ensured by the automation of diagnostic centers in Hong Kong and the UK, which minimizes operational risks. Summing market capitalization and net debt allows for the determination of the actual acquisition cost of an asset; therefore, analyzing the enterprise value inclusive of liabilities helps investors assess the efficiency of the capital structure and avoid overpaying for the company.